» Articles » PMID: 30682190

Bronchiectasis in Patients Hospitalized with Acute Exacerbation of COPD in Spain: Influence on Mortality, Hospital Stay, and Hospital Costs (2006-2014) According to Gender

Overview
Journal PLoS One
Date 2019 Jan 26
PMID 30682190
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The objectives of this study were to analyze the characteristics of male and female patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) during 2006-2014 according to the presence or absence of bronchiectasis and to study the factors associated with in-hospital mortality (IHM) in patients hospitalized with AE-COPD and concomitant bronchiectasis.

Methods: We used the Spanish National Hospital Database to analyze patients admitted with AE-COPD as their primary diagnosis. Patients included in the study were stratified according to the presence or absence of bronchiectasis as their secondary diagnosis.

Results: We identified 386,646 admissions for AE-COPD, of which 19,679 (5.09%) involved patients with concomitant bronchiectasis. When patients with and without bronchiectasis were compared, we observed that the incidence of infection by Pseudomonas aeruginosa was substantially higher in the former, as were the mean stay, cost, and percentage of readmissions, although IHM and comorbidity were lower. The course of patients with AE-COPD and bronchiectasis was characterized by a gradual increase in prevalence and mean age among men and no differences in prevalence or lower mean age in women. Mortality was 4.24% and 5.02% in patients with and without bronchiectasis, respectively, although significance was lost after a multivariate adjustment (OR 0.94; 95% CI, 0.88-1.01). The factors associated with IHM were older age, higher comorbidity, isolation of P. aeruginosa, mechanical ventilation and readmission.

Conclusions: The prevalence of admission with AE-COPD and bronchiectasis increased in men but not in women during the study period. In patients hospitalized with AE-COPD, we did not find differences in mortality when comparing the presence and absence of bronchiectasis. The analysis of temporal trends revealed a significant reduction in mortality from 2006 to 2014 in male patients with COPD and concomitant bronchiectasis, but not among women. It is important to consider the factors associated with IHM such as age, comorbidity, isolation of P. aeruginosa, mechanical ventilation and readmission to better identify those patients who are at greater risk of dying during hospitalization.

Citing Articles

Characteristics of Bronchiectasis Associated with Chronic Obstructive Pulmonary Disease.

Deghdegh K, Boukadoum N, Terra B, Amoura K, Benali R Open Respir Med J. 2023; 16:e187430642203311.

PMID: 37273954 PMC: 10156028. DOI: 10.2174/18743064-v16-e2203311.


Impact of Bronchiectasis on COPD Severity and Alpha-1 Antitrypsin Deficiency as a Risk Factor in Individuals with a Heavy Smoking History.

Izquierdo M, Marion C, Genese F, Newell J, ONeal W, Li X Chronic Obstr Pulm Dis. 2023; 10(3):199-210.

PMID: 37199731 PMC: 10484491. DOI: 10.15326/jcopdf.2023.0388.


Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study.

Ullah M, Parthasarathi A, Siddaiah J, Vishwanath P, Upadhyay S, Ganguly K Toxics. 2022; 10(11).

PMID: 36355958 PMC: 9695923. DOI: 10.3390/toxics10110667.


Increasing prevalence and burden of bronchiectasis in urban Chinese adults, 2013-2017: a nationwide population-based cohort study.

Feng J, Sun L, Sun X, Xu L, Liu L, Liu G Respir Res. 2022; 23(1):111.

PMID: 35509081 PMC: 9066779. DOI: 10.1186/s12931-022-02023-8.


Respiratory and Peripheral Muscle Weakness and Body Composition Abnormalities in Non-Cystic Fibrosis Bronchiectasis Patients: Gender Differences.

Wang X, Balana-Corbero A, Martinez-Llorens J, Qin L, Xia Y, Zha J Biomedicines. 2022; 10(2).

PMID: 35203543 PMC: 8961780. DOI: 10.3390/biomedicines10020334.


References
1.
Gatheral T, Kumar N, Sansom B, Lai D, Nair A, Vlahos I . COPD-related bronchiectasis; independent impact on disease course and outcomes. COPD. 2014; 11(6):605-14. DOI: 10.3109/15412555.2014.922174. View

2.
. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1545-1602. PMC: 5055577. DOI: 10.1016/S0140-6736(16)31678-6. View

3.
Martinez-Garcia M, Miravitlles M . Bronchiectasis in COPD patients: more than a comorbidity?. Int J Chron Obstruct Pulmon Dis. 2017; 12:1401-1411. PMC: 5436792. DOI: 10.2147/COPD.S132961. View

4.
Martinez-Garcia M, de la Rosa Carrillo D, Soler-Cataluna J, Donat-Sanz Y, Catalan Serra P, Lerma M . Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 187(8):823-31. DOI: 10.1164/rccm.201208-1518OC. View

5.
Ginde A, Tsai C, Blanc P, Camargo Jr C . Positive predictive value of ICD-9-CM codes to detect acute exacerbation of COPD in the emergency department. Jt Comm J Qual Patient Saf. 2008; 34(11):678-80. DOI: 10.1016/s1553-7250(08)34086-0. View